Products & ReviewLife Sciences
Twist Anti-SARS-CoV-2 S1 Antibodies
Twist Biopharma has developed a set of antibodies that targets the SARS-CoV-2 Spike Protein with high binding affinity and specificity. Several antibodies also show the ability to block S1 binding to ACE2.
Request Pricing
Receive your quote directly from the manufacturer.
Twist Biopharma’s human antibodies that target the SARS-CoV-2 Spike Protein have a potential dual-purpose and could be developed either for virus neutralization or detection in therapeutic and diagnostic applications, respectively.
